Heptares

Develops small molecule drugs targeting GPCRs

placeWelwyn Garden City, England, United Kingdom calendar_todayFounded 2007 groups168 employees language heptares.com

Registered entities

Investor mix

7 investors on record; lead investors include Stanley Medical Research Institute; 1 has since exited.

Investor typeCountShare
Venture capital229%
Private equity229%
Other / undisclosed343%
Coming soon